Integrating Macrophages into Organotypic Co-Cultures: A 3D In Vitro Model to Study Tumor-Associated Macrophages

Tumor progression is controlled by signals from cellular and extra-cellular microenvironment including stromal cells and the extracellular matrix. Consequently, three-dimensional in vitro tumor models are essential to study the interaction of tumor cells with their microenvironment appropriately in a biologically relevant manner. We have previously used organotypic co-cultures to analyze the malignant growth of human squamous cell carcinoma (SCC) cell lines on a stromal equivalent in vitro. In this model, SCC cell lines are grown on a collagen-I gel containing fibroblasts. Since macrophages play a critical role in the progression of many tumor types, we now have expanded this model by integrating macrophages into the collagen gel of these organotypic tumor co-cultures. This model was established as a murine and a human system of skin SCCs. The effect of macrophages on tumor progression depends on their polarization. We demonstrate that macrophage polarization in organotypic co-cultures can be modulated towards and M1 or an M2 phenotype by adding recombinant IFN-γ and LPS or IL-4 respectively to the growth medium. IL-4 stimulation of macrophage-containing cultures resulted in enhanced tumor cell invasion evidenced by degradation of the basement membrane, enhanced collagenolytic activity and increased MMP-2 and MMP-9. Interestingly, extended co-culture with tumor cells for three weeks resulted in spontaneous M2 polarization of macrophages without IL-4 treatment. Thus, we demonstrate that macrophages can be successfully integrated into organotypic co-cultures of murine or human skin SCCs and that this model can be exploited to analyze macrophage activation towards a tumor supporting phenotype.

[1]  N. Fusenig,et al.  IL‐6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines , 2011, International journal of cancer.

[2]  N. Fusenig,et al.  Constitutive expression of G‐CSF and GM‐CSF in human skin carcinoma cells with functional consequence for tumor progression , 1999, International journal of cancer.

[3]  L. Sundstrom,et al.  A macrophage hippocampal slice co-culture system: application to the study of HIV-induced brain damage , 1999, Journal of Neuroscience Methods.

[4]  T. Wynn,et al.  Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[5]  N. Fusenig,et al.  Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes , 1998, Molecular carcinogenesis.

[6]  S. Ugurel,et al.  Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis , 2006, The Journal of pathology.

[7]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[8]  Saumyadipta Pyne,et al.  Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors , 2010, Proceedings of the National Academy of Sciences.

[9]  M. Skobe,et al.  Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. , 2010, The American journal of pathology.

[10]  N. Fusenig,et al.  c-Jun and JunB Antagonistically Control Cytokine-Regulated Mesenchymal–Epidermal Interaction in Skin , 2000, Cell.

[11]  N. Fusenig,et al.  Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. , 1998, Experimental cell research.

[12]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: an underestimated tool is catching up again. , 2010, Journal of biotechnology.

[13]  J. Pastor,et al.  Müller and macrophage-like cell interactions in an organotypic culture of porcine neuroretina , 2008, Molecular vision.

[14]  A. Bohnert,et al.  Basement membrane formation by malignant mouse keratinocyte cell lines in organotypic culture and transplants: correlation with degree of morphologic differentiation , 2004, Journal of Cancer Research and Clinical Oncology.

[15]  N. Fusenig,et al.  Organotypic cocultures as skin equivalents: A complex and sophisticated in vitro system , 2004, Biological Procedures Online.

[16]  J. Pollard Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.

[17]  P. Friedl,et al.  Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.

[18]  J. Pollard,et al.  Macrophages define the invasive microenvironment in breast cancer , 2008, Journal of leukocyte biology.

[19]  P. Allavena,et al.  The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.

[20]  M. Decossas,et al.  A new organotypic model containing dermal‐type macrophages , 2011, Experimental dermatology.

[21]  E. Borden,et al.  Effect of interferon alpha, interferon beta, and interferon gamma on the in vitro growth of human renal adenocarcinoma cells , 2004, Investigational New Drugs.

[22]  Mayte Suárez-Fariñas,et al.  Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. , 2011, The Journal of investigative dermatology.

[23]  N. Fusenig,et al.  Cooperative Autocrine and Paracrine Functions of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in the Progression of Skin Carcinoma Cells , 2004, Cancer Research.

[24]  Alessandra Pavesio,et al.  Epidermal homeostasis in long-term scaffold-enforced skin equivalents. , 2006, The journal of investigative dermatology. Symposium proceedings.

[25]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[26]  Alberto Mantovani,et al.  Tumor-Conditioned Macrophages Secrete Migration-Stimulating Factor: A New Marker for M2-Polarization, Influencing Tumor Cell Motility , 2010, The Journal of Immunology.

[27]  N. Fusenig,et al.  Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. , 1999, The Journal of investigative dermatology.

[28]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[29]  Mikala Egeblad,et al.  Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.

[30]  J. Pollard,et al.  Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages , 2007, Molecular oncology.

[31]  T. Wynn,et al.  The IL-21 receptor augments Th2 effector function and alternative macrophage activation. , 2006, The Journal of clinical investigation.

[32]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[33]  J. Hershman,et al.  Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines. , 1995, The Journal of clinical endocrinology and metabolism.

[34]  Matthew J. Craig,et al.  CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization* , 2009, The Journal of Biological Chemistry.

[35]  G. Livera,et al.  Organotypic culture, a powerful model for studying rat and mouse fetal testis development , 2006, Cell and Tissue Research.

[36]  A. Bohnert,et al.  Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. , 1983, The Journal of investigative dermatology.

[37]  K. Ogawa,et al.  Activin A Functions as a Th2 Cytokine in the Promotion of the Alternative Activation of Macrophages1 , 2006, The Journal of Immunology.

[38]  N. Fusenig,et al.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. , 2006, Cancer research.

[39]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[40]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.